News & insights

Dosage regimen patents at the EPO part (I): Strategic tips for success

Technical Tips

Dosage regimen patents at the EPO part (I): Strategic tips for success

Dosage regimen claims typically refer to compounds for use in treating a condition at a specific frequency of administration, at a specific dose or within a specific dosage range. Sometimes further fe...

Prior use ''pitfalls'' – three key tips for success in EPO oppositions

Technical Tips

Prior use ''pitfalls'' – three key tips for success in EPO oppositions

This practical update takes a look at how best to use public prior use in an EPO opposition and the potential pitfalls to avoid.

Part 2 Avoiding pitfalls: Protection for new uses in Europe at the interface of therapy and non-therapy

Technical Tips

Part 2 Avoiding pitfalls: Protection for new uses in Europe at the interface of therapy and non-therapy

In the second part of our series looking at claiming new uses in Europe, we take a deep dive into the EPO case law relating to use claims at the interface between therapeutic and non-therapeutic uses ...

Formulated for success: Patenting pharmaceutical formulations in Europe

Technical Tips

Formulated for success: Patenting pharmaceutical formulations in Europe

Patent applications to pharmaceutical formulations can play an important role in patent strategies for drug products. Provided that the formulation is associated with an unexpected benefit, it can cre...

Part 1 Avoiding pitfalls: Protection for new uses in Europe at the interface of therapy and non-therapy

Technical Tips

Part 1 Avoiding pitfalls: Protection for new uses in Europe at the interface of therapy and non-therapy

Claims to a new use can be a valuable part of a patent portfolio in Europe, allowing patentees to obtain protection for a product even if the product is already known for a different use.

The difference between dupes and counterfeits: What consumers and IP Rights owners need to know

Technical Tips

The difference between dupes and counterfeits: What consumers and IP Rights owners need to know

As Black Friday approaches, shoppers are gearing up to find deals on everything; from luxury cosmetics to designer handbags.

Parameters at the EPO: Tips and common pitfalls

Our favourite articles of 2024

Parameters at the EPO: Tips and common pitfalls

Many inventions, particularly in the chemical field, are defined by ‘parameters’ rather than structural features. Parameters are measurable physical or chemical properties used to define an invention ...

Fashion fortified: top tips to combat counterfeiting

Our favourite articles of 2024

Fashion fortified: top tips to combat counterfeiting

Celebrating its 40th year, London Fashion Week is upon us and as the hype of people’s fashions on and off the catwalk grips our attention, now is a good time for brand owners and designers to reflect ...

More than the sum of their parts: chimeric antigen receptors (CARs) and the significance of data and examples

Technical Tips

More than the sum of their parts: chimeric antigen receptors (CARs) and the significance of data and examples

Chimeric antigen receptors (CARs) often comprise a combination of known cellular domains. Consequently, experimental data is usually critical for demonstrating an inventive step.

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us